The in vivo tumor-initiating properties of cells are also hallmarks of CSCs; hence, we performed an in vivo tumorigenicity assay by subcutaneously transplanting the stable IFIT2 knockdown and sh-control cells into the flanks of the nude mice. The gene discussed is IFIT2; the disease is neoplasm.